Assessing Benefits Of Treatment Of Dental Caries Using 38% Silver Diamine Fluoride And Placebo Among Primary School Children In Hyderabad City: A Randomized Controlled Trial.
Phase 1
- Conditions
- Health Condition 1: K026- Dental caries on smooth surface
- Registration Number
- CTRI/2020/11/029210
- Lead Sponsor
- H Sai Sandeep
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children having at least one untreated cavitated active caries lesion based on Nyvad criteria.[code :3 Enamel/dentin cavity easily visible with the naked eye; surface of cavity feels soft or leathery on gentle probing ]
ï?¢ Parents who gave written informed consent .
Exclusion Criteria
Children not willing to participate in the study
ï?¢ Presence of any gingival or perioral ulceration or stomatitis or presence of a tooth abscess.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Caries arrestTimepoint: 30 days
- Secondary Outcome Measures
Name Time Method Inhibits caries progressionTimepoint: 30 Days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the caries-arresting effects of 38% silver diamine fluoride in primary teeth?
How does 38% silver diamine fluoride compare to standard-of-care treatments like fluoride varnish in arresting dental caries in children?
Are there specific biomarkers that can predict response to silver diamine fluoride in caries management?
What are the potential adverse events associated with 38% silver diamine fluoride application in pediatric populations?
What combination therapies or alternative compounds are being explored alongside silver diamine fluoride for dental caries treatment?